Latest news
Aurion Biotech Doses First Patients in US Phase 3 Trial of Regenerative Cell Therapy for Corneal Disease - eyewire.newseyewire.news · Tue, 04 Aug 2026 07:00:00 GMTAgnico Eagle Accelerates Finnish Expansion with Central Lapland Acquisitions in Q2 2026 - The Globe and MailThe Globe and Mail · Thu, 30 Jul 2026 21:38:00 GMTAurion.AI Files Application for Rs750m PSX IP - Digital PakistanDigital Pakistan · Wed, 29 Jul 2026 14:00:21 GMT